Literature DB >> 18789906

Cajal-Retzius cells fail to trigger the developmental expression of the Cl- extruding co-transporter KCC2.

Esther Pozas1, Sonia Paco, Eduardo Soriano, Fernando Aguado.   

Abstract

Cajal-Retzius (CR) cells are transient neurons of the developing cerebral cortex that play a pivotal role in the lamination and construction of neural circuits. One physiological feature of CR cells is the failure to switch GABAergic transmission from excitation to inhibition. To examine the mechanisms underlying the persistence of the depolarizing action of GABA we analyzed the mRNA expression of the K+/Cl- co-transporter type 2 (KCC2) in mouse CR by in situ hybridization. During the second postnatal week, the developmentally regulated expression of KCC2 reached adult levels in most neurons of the cerebral cortex. Double labeling with the CR-cell marker calretinin and KCC2 in situ hybridization showed that CR cells were consistently devoid of KCC2 expression in several cortical areas such as neocortex and hippocampus. Since most cortical calretinin- and calbindin-containing non-CR neurons did express KCC2 mRNA, we conclude that CR cells specifically fail to trigger the developmental expression of the K+/Cl- co-transporter KCC2. These results suggest that absence of KCC2 preserves the depolarizing action of GABA in CR cells and support the notion that KCC2 is a key factor controlling Cl- homeostasis and preventing hyperexcitability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789906     DOI: 10.1016/j.brainres.2008.08.058

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Activity-dependent scaling of GABAergic excitation by dynamic Cl- changes in Cajal-Retzius cells.

Authors:  Sergey N Kolbaev; Heiko J Luhmann; Werner Kilb
Journal:  Pflugers Arch       Date:  2011-02-19       Impact factor: 3.657

2.  Effects of ethanol exposure in utero on Cajal-Retzius cells in the developing cortex.

Authors:  Alexander G J Skorput; Hermes H Yeh
Journal:  Alcohol Clin Exp Res       Date:  2015-04-06       Impact factor: 3.455

3.  The chemokine CXCL12 and the HIV-1 envelope protein gp120 regulate spontaneous activity of Cajal-Retzius cells in opposite directions.

Authors:  Ivan Marchionni; Michael Beaumont; Gianmaria Maccaferri
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

4.  Distinctive properties of CXC chemokine receptor 4-expressing Cajal-Retzius cells versus GABAergic interneurons of the postnatal hippocampus.

Authors:  Ivan Marchionni; Virág T Takács; Maria Grazia Nunzi; Enrico Mugnaini; Richard J Miller; Gianmaria Maccaferri
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

Review 5.  Modulation of hippocampal stratum lacunosum-moleculare microcircuits.

Authors:  Gianmaria Maccaferri
Journal:  J Physiol       Date:  2010-12-06       Impact factor: 5.182

Review 6.  Cajal-Retzius cells and GABAergic interneurons of the developing hippocampus: Close electrophysiological encounters of the third kind.

Authors:  Max Anstötz; Giulia Quattrocolo; Gianmaria Maccaferri
Journal:  Brain Res       Date:  2018-07-30       Impact factor: 3.252

7.  Novel GABAergic circuits mediating excitation/inhibition of Cajal-Retzius cells in the developing hippocampus.

Authors:  Giulia Quattrocolo; Gianmaria Maccaferri
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

8.  mGlu1α-dependent recruitment of excitatory GABAergic input to neocortical Cajal-Retzius cells.

Authors:  Kathleen E Cosgrove; Gianmaria Maccaferri
Journal:  Neuropharmacology       Date:  2012-05-09       Impact factor: 5.250

9.  Chemokines and HIV-1 virus: opposing players in Cajal-Retzius cell function.

Authors:  Marco Capogna
Journal:  J Physiol       Date:  2012-07-01       Impact factor: 5.182

10.  Loss of non-canonical KCC2 functions promotes developmental apoptosis of cortical projection neurons.

Authors:  Martin Puskarjov; Martina Mavrovic; Pavel Uvarov; Eric Delpire; Laszlo Vutskits; Kai Kaila
Journal:  EMBO Rep       Date:  2020-02-17       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.